Skip to main content

Protective role of heparin in the injury of the liver and kidney on the experimental model of ischemia/reperfusion



Surgery of thoracoabdominal aortic aneurysms (TAAA) is associated with high incidence of serious complications. Ischemia/reperfusion (I/R) injury may be responsible for these complications. We investigated the effect of degree of anticoagulation on remote organ I/R injuries and whether heparin is protective against I/R injury in addition to its anticoagulant properties.


Spraque Dawley rats were used to determine both liver and kidney concentrations of HSP-70,IL-6, MPO in four groups: ischemic control (operation with cross-clamping and intraperitoneal administration of 0.9% saline, n = 7), sham (operation without cross-clamping, n = 7), heparin (ACT level about 200), and high dose heparin (ACT level up to 600). Histological analyses of the organs were performed.


Histopathological evaluation of kidney presented significant differences between groups with regards to the cytoplasmic vacuole formation, hemorrhage, tubular cell degeneration and tubular dilatation while heparinized group had best results. The kidney MPO and HSP-70 levels significantly decreased (p < 0.05), but IL-6 level was not significant (p > 0.05) in heparinized group when compared to ischemic control group. No statistically significant intergroup differences were detected in the tissue samples of liver. Immunohistochemical markers of the liver were compared and no statistically significant difference was found among the groups.


Heparin is an important anticoagulation agent in TAAA surgical procedures but the use of higher levels of heparin in the present study revealed no beneficial effects. Bleeding complications is much less when heparin is used in the real-world clinical practice as ACT levels of 200.

Peer Review reports


Surgical repair of thoracoabdominal aortic aneurysms (TAAAs) are highly complex and challenging interventions. It is not surprising that this operation is associated with a high incidence of serious complications, often leading to respiratory failure, renal failure, neurological deficits or even death.

Multiorgan dysfunction, presumably related to activation of inflammatory pathways and over production of cytokines and other inflammatory mediators, is a major cause of death. The systemic inflammatory response syndrome (SIRS), ischemia-reperfusion injury (I/Ri), and inflammatory pathway activation are considered precursors of morbidity and mortality after open TAAA repair [13].

Cytokines such as IL-6 are important mediators of the inflammatory response in ischemia. Plasma IL-6 concentration increased gradually, reached its peak 24 hours after surgery, and correlated with aortic cross-clamp time and morbidity. The observed correlation between plasma IL-6 and aortic cross-clamp time supports the hypothesis that the IL-6 response mainly reflects the impact of ischemia and reperfusion rather than the impact of surgical trauma in elective TAAA surgery. The strong correlation between plasma IL-6 and morbidity in previous reports suggesting that plasma IL-6 is a reliable predictor of outcome in elective TAAA repair [46].

Heat shock proteins (HSPs) are cellular stress proteins which have been shown to have an important role for the survival of cells under stress conditions [7]. Zhang et al. [8] pointed out that, HSP70 could respond to a wide variety of stress conditions such as ischemia, and inflammation. It can prevent the irreversible denaturation of proteins [9]. Elevated expression of HSP70 can prevent cell death processes [10]. It has been showed that overexpression of HSP70 attenuate the release of inflammatory factors and interferes with the process of apoptotic cell death [1012].

Myeloperoxidase (MPO) is one of the obvious indicators for the tissue infiltration of neutrophilic granulocytes. MPO activity increases in response to the I/R injury [13].

Heparin continues to dominate anticoagulation therapy for surgical repair of TAAA and other cardiovascular surgical procedures. Heparin is best recognized for its ability to prevent blood coagulation by catalytically accelerating the interaction of antithrombin III (AT III) with thrombin, as well as with factors XIIa, IXa, Vlla, and Xa, thereby inhibiting the proteases necessary for completion of the coagulation cascade [14].

Beside heparin is known to possess effects independent of its anticoagulant activity, it plays a role in inhibition of leukocyte-mediated damage [15, 16]. Other important and often unrecognized actions of heparin and other glycosaminoglycans are their ability to inhibit complement activation [17] and to exhibit anti-inflammatory effects [1820].

In this study, we investigated the effect of the degree of anticoagulation on remote organ I/R injury and whether heparin is protective against I/R injury beside its anticoagulant properties.


Animal and surgical procedure

This study was approved by the Animal Experiment Committee of Düzce University Graduate School of Medicine and all animal care and use were in accordance with the European Convention for Animal Care. 28 male Sprague–Dawley rats weighing 250 to 350 g were used for the experiment. Rats were fed standard laboratory diets and were maintained in a temperature- and photoperiod-controlled (12 hr/day) room. The rats were followed for 15 days before the procedure. None of the animals had any abnormality before operation.

Study groups

The animals were randomly divided into four groups (7 rats each). 1) Sham-operation group. The operation was performed in the same form, but without aortic occlusion and heparin administration. 2) Non- heparinized control group rats’ abdominal aortas were clamped for 45 minutes. 3) Low-dose heparin treated group animals’ aortas were cross-clamped for 45 minutes and 400 IU/kg of heparin was administered. ACT was kept around 200 during the procedure. 4) High-dose heparin treated group. In this group rats’ aortas was cross-clamped for 45 minutes and 800 IU/kg of heparin was administered. ACT was kept around 600 during the procedure.

Operative procedure and technique

Premedication was intraperitoneally applied with ketamine (50 mg/kg) and xylazine (5 mg/kg) to rats. Anesthesia was continued by intermittent injections of ketamine, without endotracheal intubation and mechanical ventilation. Temperature probe was placed in the rectum.

Rats were placed in supine position. After sterile preparation of the surgical area, a standard midline laparotomy incision was made, and after the intestines were retracted the abdominal aorta was explored transperitoneally.The abdominal aorta at the below renal arteries and above the iliac bifurcation levels was cross-clamped during surgical procedures. The duration of the ischemic insult was 45 minutes. Temperature was maintained between 36.5 and 37.5°C during the procedure. Following removal of the aortic clamps, abdominal wall was repaired by using 5/0 polyprolene suture. Penthobarbital (20 mmg/kg) was used as anesthetic at the 48th hour and all the animals were sacrificed. The liver and kidney was dissected totally and fixed in buffered formalin for 7 days.

Histopahological assessment

The liver and kidney were removed and fixed in 10% formalin for histopathologic examination. About 4 μm thick paraffin sections were cut and collected on glass slides. 5 μm thick sections were located on polylysine-coated slides and were stained with hematoxylin and eosin (H & E). The glass slides were examined by light microscopy (Olympus BX51; Olympus Corp. Tokyo, Japan) at 400× magnification.

Immunohistochemical assessment

Blood samples were obtained directly from the cardiac of groups of four rats at the end of 48 h immediately before the sacrification. Blood samples were obtained with sterile 10 ml syringe after the chest wall was cleansed with cholorohexidine in spirit. Blood samples for cytokine assay were collected into heparinized (20 unit/ml blood) sterile tubes and immediately transferred on ice to be centrifuged at 2000 rpm (at 4°C) for 10 minutes and stored (-70°C) until the time of assay for IL-6, MPO and HSP-70. These marker levels were obtained from blood samples together with kidney and liver tissue.

Analysis of HSP

4 μm thick paraffin sections were prepared. Deparaffinization and hydration of tissue sections was performed in xylenes and graded alcohol. The sections were incubated with primary anti-HSP70 (clone BRM.22, dilution 1/80, Biogenex, San Ramon, California) diluted in buffer. Negative control was PBS.

Analysis of IL-6

Immunohistochemical detection of IL-6 receptor was performed with polyclonal anti-human IL-6 receptor antibody C-20 (Santa Cruz Biotechnologies, Santa Cruz, CA, USA). The antibody was diluted 1: 20. Streptavidin-biotin-peroxidase protocol was applied in IL-6 receptor immunostaining. The secondary anti-rabbit antibody was diluted 1: 500. After the first antibody was omitted negative controls were conducted.

Analysis of MPO

Immuno-histochemical evaluation of MPO activities of the liver and kidney tissues was performed with an anti-MPO kit according to the manufacturer’s protocol. Deparaffinization and hydration of samples on polylysine-coated slides was performed. Then, the microwave antigen retrieval procedure was performed, and the samples were incubated in a 3% H2O2 solution to inhibit endogenous peroxidase. The sections were incubated with a blocking solution for blocking nonspecific background staining. Then incubation of the sections with primary anti-MPO antibody and with biotinylated goat anti-mouse antibody followed. After incubation with chromogenic substrate (DAB), the sections were counterstained with hematoxylin and eosin (H & E). The slides were examined under a light microscope and two pathologists who did all analyses were blinded to group assignments. The staining of cytoplasmic MPO in the neutrophils was evaluated, and the results were expressed as the percentage of neutrophils cytoplasmically stained positive for MPO. Tissues with no evidence of staining, or only rare scattered positive cells, less than 3%, were recorded as negative. The immunohistochemical results were evaluated for intensity and frequency of staining. The intensity of staining was graded as 0 (negative), 1 (weak), 2 (moderate), and 3 (strong). The frequency was graded from 0 to 4 by the percentage of positive cells as follows: grade 0, <3%; grade 1, 3-25%; grade 2, 25-50%; grade 3, 50-75%; grade 4, more than 75%. The index score was the product of multiplication of the intensity and frequency grades, which was then classified into a 4 point scale: index score 0 = product of 0, index score 1 = products 1 and 2, index score 2 = products 3 and 4, index score 3 = products 6 through 12.

Statistical analysis

Statistical analysis and calculations were performed with SPSS 15 for Windows (Chicago, IL). Results were expressed as the mean (standard error mean). Intergroup differences are detected by Kruskal-Wallis analysis of variance and Mann–Whitney U test was used for statistical comparisons. While p value of < .01 was accepted as statistically significant p value of < .05 was accepted as statistically less significant.


There was no significant difference with regards to body temperature, mean arterial blood pressure and heart rate among the groups.

Histopathological evaluation of the tissue samples taken from the kidney showed significant intergroup differences in terms of the cytoplasmic vacuole formation, hemorrhage, tubular cell degeneration and tubular dilatation (P = 0.031, P = 0.003, P = 0.007, P = 0.011 respectively).

There was no cytoplasmic vacuole formation in the kidney specimens of high dose-heparinized group, while cytoplasmic vacuole formation was evident in the other animals’ kidney; as shown in Table 1.

Table 1 Histopathologic results of the kidney tissue

As depicted in Table 2, heparinized group of the examination compared with other groups showed no hemorrhage according to histopathologic evaluation. Hemorrhage was worst in the ischemic control group followed by sham and high dose-heparinized group. Hemorrhage in the kidney specimens of high dose-heparinized group may be due to high levels of ACT (Table 1).

Examination of the kidney tissue revealed that ischemic control group showed most tubular cell degeneration according to histopathologic evaluation (P = 0.007); whereas there was no degeneration in the high dose-heparinized group.

There was no tubular dilatation in the kidney specimens of sham and heparinized groups while tubular dilatation was worst in the ischemic control group (P = 0.011).

Immunohistochemical markers as, MPO, HSP-70 and IL-6 parameters were studied from the kidney tissue samples. While there was no intergroup difference with regards to IL-6 stain (p = 0.205), there were statistical significant differences among the groups with regards to MPO and HSP-70 stains (p value 0.01 and 0.004, respectively) (Table 2). Grade 1, 2 and 3 staining with MPO was strongest in the ischemic control group and high dose-heparinized group whereas there was no staining in the heparinized group (P = 0.01). The lowest HSP-70 level was measured in the sham group, after heparinized groups while the highest HSP-70 level was measured in the high dose-heparinized and ischemic control group. IL6 staining results are given in Table 2. There was no significant difference found among the groups (P = 0.205).

Table 2 Immunohistochemical results of the kidney tissue

Histopathological evaluation of the tissue samples taken from the liver showed no statistically significant intergroup differences in terms of the hepatocyte degeneration, hepatocyte steatosis, single cell necrosis, inflammatory cell, sinusoidal dilatation and periportal bridging necrosis (P = 0.587, P = 0.277, and P = 0.196 respectively) (Table 3).

Table 3 Histopathological results of the liver tissue

Comparison of immunohistochemical markers of the ischemia- reperfusion injury of the liver tissue in an aortic occlusion model of rats revealed that there was no statistically significant difference found among the groups in terms of MPO, HSP70 and IL-6 (P = 0.152, P = 0.053, and P = 0.243 respectively) (Table 4).

Table 4 Immunohistochemical results of the liver tissue


Despite contemporary approaches to organ protection, open abdominal aortic aneurysm (AAA) repair is still associated with significant morbidity and mortality in high-risk patients [21]. Multiple organ failure (i.e., the lung, kidney) and spinal cord injury are related with activation of inflammatory pathways and over production of other inflammatory mediators during the thoracoabdominal aortic surgery [22, 23]. Thoracoabdominal aortic clamping can lead to systemic inflammatory response and ischemia occurs as the blood flow through the major arteries supplying blood to remote organs slows down or stops [24, 25].

Among various factors that has been related with end organ ischemia/reperfusion injury such as distal aortic hypotension after aortic occlusion, duration of ischemia and aneurysm extent and microthrombus formation are most important and avoidable factors [26]. So microthrombus formation associated with blood flow slowing, stopping and inadequate heparin dose can cause multiorgan disorders together with histopathological and functional changes [27, 28]. Especially, when the hematocrit level is higher than 40 mg/dl microthrombus may easily form. It was suggested that microcirculatory disturbances such as higher blood viscosity characterized by hemoconcentration and microthrombus formation were associated with ischemia [29].

Heparin still remains the leading drug in the management of anticoagulation. Not only heparin has anticoagulant activity but also it has direct anti-inflamatory action. The role of heparin as an anti-inflamatory and anticoagulant agent has a wide spectrum of interactions with various enzymes, hormones, biogenic amines, and plasma proteins. There is great variability in plasma concentration of heparin in relation to dose, so the anticoagulant response is not linear. To provide equilibrium between preventing coagulation and in the mean time preventing excessive bleeding is difficult. This difficulty has increased the importance of the identification of the level of anticoagulation. The most popular and predominant test to monitor anticoagulation is ACT, so we thought to investigate the effect of ACT levels on end organ ischemia in an experimental model.

The presence of patients with postoperative organ dysfunction relationships with response of plasma inflammatory mediators after I/Ri. The overexpression and release of inflammatory mediators, cytokines, activation of phospholipase A2 and complement system, effects of adhesion molecules, activation of arachidonic acid system make I/R injury very complicated and difficult to understand [3032]. Actually, ischemia and reperfusion is a chain reaction resulting in free oxygen radical generation, respiratory burst of activated neutrophils that occurs in response to tissue injury and the autooxidation of cathecolamines [8]. Severin et al. [33] reported that heparin has anti-inflammatory properties beside its anti-coagulant effects. This characteristic of heparin has been attributed to binding certain cytokines, like chemokines which mediate inflammation through their control of leukocyte migration and activation. We investigated the levels of IL-6, MPO and HSP-70 to evaluate the inflammatory response to I/R injury and the effect of heparin on it.

Acute phase proteins, myeloperoxidase and IL-6 are increase with inflammation [5, 34]. HSP-70, a well known cytoprotective agent increases after I/R and its level is directly correlated with the degree of tissue injury and inflammation. In the present study ,the lowest HSP-70 and MPO level in kidney tissue was measured in the sham group and heparinized groups, showed that the inflammation and injury was significantly lower with this treatment. The decrease in HSP-70 in these groups also was an indirect proof of lower tissue injury and better cellular protection. We could not find a significant difference between the groups in terms of the degree of inflammatory response, degree of IL6 kidney tissue.

Cytoplasmic vacuole formation, hemorrhage, tubular cell degeneration and tubular dilatation in the kidney tissue after I/R were decreased after heparin treatment and the histopathologic protective effect of heparin was shown in the present study.

Comparison of immunohistochemical markers and histopathological evaluation of the ischemia- reperfusion injury of the liver tissue in an aortic occlusion model of rats revealed that there was no statistically significant difference. The reason for this outcome for us that; the afferent blood supply to the liver arises from two sources: (i) the hepatic artery, which carries oxygenated blood and accounts for approximately 25% of hepatic blood flow and 50% of total oxygen, and (ii) the portal vein, which drains the splanchnic circulation and accounts for approximately 75% of hepatic blood flow. Because of its protection by a dual blood supply and the capacity for anaerobic metabolism of glycogen stored in the liver, hypoxic damage can occur later in this organ [35].

The half-life of heparin is approximately 30 minutes, 60 minutes and 150 minutes respectively following IV bolus of 25 U/kg, 100 U/kg and 400 U/kg [36]. Our clinical routine in abdominal aortic surgery is to administer bolus of 100 U/kg heparin and to maintain ACT level around 200 seconds. In the present study there was no significant difference between heparin groups (ACT: 200 and ACT: 600) in terms of histopathologic changes or biochemical inflammatory response in the liver and kidney. Also, keeping ACT level around 200 sec during thoracoabdominal surgery seems both to ensure the adequate level of anticoagulation and to avoid the adverse effects such as bleeding.


Many current analysis clearly evidences that the surgical repair of TAAA remains a challenge even in this century. Recent major progress in our understanding of the pathophysiology and operative strategy have decreased the risk of open TAAA repair complications but obviously further investigation is necessary. Heparin is an important anticoagulation agent in thoracoabdominal and abdominal surgical procedures but no beneficial effects were seen with the use of higher levels of heparin in the present study. Taking into account that, bleeding complications will be much less when heparin used in the real-world clinical practice as ACT levels of 200. Furthermore, the results of this investigation indicate that heparin molecule has provide to potential anti-inflammatory property and renal protective action.



Thoracoabdominal aortic aneurysm






Heat shock protein 70


Activated clotting time


Systemic inflammatory response syndrome


Antithrombin III


Ischemia reperfusion


Ischemia reperfusion injury

H & E:

Hematoxylin and eosin.


  1. 1.

    Vasdekis SN, Argentou M, Kakisis JD, Bossios A, Gourgiotis D, Karanikolas M, Karatzas G: A global assessment of the ınflammatory response elicited upon open abdominal aortic aneurysm repair. Vasc Endovasc Surg. 2008, 42 (1): 47-53.

    Article  Google Scholar 

  2. 2.

    Walker PM: Ischemia/reperfusion ınjury in skeletal muscle. Ann Vasc Surg. 1991, 5 (4): 399-402.

    CAS  Article  PubMed  Google Scholar 

  3. 3.

    Bown MJ, Nicholson M, Bell PR, Sayers RD: Cytokines and ınflammatory pathways in the pathogenesis of multiple organ failure following abdominal aortic aneurysm repair. Eur J Vasc Endovasc Surg. 2001, 22 (6): 485-495.

    CAS  Article  PubMed  Google Scholar 

  4. 4.

    Roumen RM, Hendriks T, Van Der Ven-Jongekrijg J: Cytokine patterns in patients after major vascular surgery, hemorrbagie sbock, and severe blunt trauma. Relation with subsequent adult respiratory distress syndrome and multiple organ failure. Ann Surg. 1993, 218: 769-776.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  5. 5.

    Adembri G, Kastamoniti E, Bertolozzi I: Pulmonary ınjury follows systemic ınflamatory reaction in ınfrarenal aortic surgery. Crit Care Med. 2004, 32: 1170-1177.

    Article  PubMed  Google Scholar 

  6. 6.

    Raijmakers PG, Groeneveld AB, Rauwerda JA, Teule GJ, Hack CE: Acute lung ınjury after aortic surgery: the relation between lung and Leg microvascular permeability to ındium-labelled transferrin and circulating mediators. Tliorax. 1997, 52: 866-871.

    CAS  Google Scholar 

  7. 7.

    Bao XQ, Lıu GT: Bicyclol: a novel antihepatitis drug with hepatic heat shock protein 27/70-ınducing activity and cytoprotective effects in mice. Cell Stress Chaperones. 2008, 13 (3): 347-355.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  8. 8.

    Zhang K, Zhao T, Huang X, Lıu ZH, Xıong L, Lı MM, Wu L, Zhao Y, Zhu L, Fan M: Preinduction of Hsp70 promotes hypoxic tolerance and facilitates acclimatization to acute hypobaric hypoxia in mouse brain. Cell Stress Chaperones. 2009, 14: 407-415.

    CAS  Article  PubMed  Google Scholar 

  9. 9.

    Latchman DS: Heat shock proteins and cardiac protection. Cardiovasc Res. 2001, 51: 637-646.

    CAS  Article  PubMed  Google Scholar 

  10. 10.

    Mosser DD, Caron AW, Bourget L, Denıs-Larose C, Massıe B: Role of the human heat shock Proteinhsp70 in protection against stress-ınduced apoptosis. Mol Cell Biol. 1997, 17: 5317-5327.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  11. 11.

    Fujibayashi T, Hashimoto N, Jijiwa M, Hasegawa Y, Kojima T, Ishiguro N: Protective effect of geranylgeranylacetone, an ınducer of heat shock protein 70, against drug-ınduced lung ınjury/fibrosis in an animal model. BMC Pulm Med. 2009, 9: 45-

    Article  PubMed  PubMed Central  Google Scholar 

  12. 12.

    Choudhury S, Bae S, Ke Q, Lee JY, Kim J, Kang PM: Mitochondria to nucleus translocation of Aıf ın mice lacking Hsp70 during ıschemia/reperfusion. Basic Res Cardiol. 2011, 106: 397-407.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  13. 13.

    Qıan M, Eaton JW, Wolff SP: Cyanate-mediated ınhibition of neutrophil myeloperoxidase activity. Biochem J. 1997, 326 (1): 159-166.

    Article  PubMed  PubMed Central  Google Scholar 

  14. 14.

    Maillet F, Petitou M, Choay J, Kazatchkine MD: Structure function relationships in the ınhibitory effect of heparin on complement actiation: ındependency of the anticoagulant and anticomplement sites on the heparin molecule. Mol Immunol. 1988, 25: 917-923.

    CAS  Article  PubMed  Google Scholar 

  15. 15.

    Redini F, Tixier J-M, Petitou M, Choay J, Robert L, Hornbeck S: Inhibition of leukocyte elastase by heparin and ıts derivatives. Biochem J. 1988, 252: 515-519.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  16. 16.

    Pasini FL, Pasqui AL, Ceccatelli L, Capecchi PL, Orrico A, Perri TD: Heparin ınhibition of polymorphonuclear leukocyte activation ın vitro: a possible pharmacological approach to granulocytemediated vascular damage. Thromb Res. 1984, 35: 527-537.

    CAS  Article  Google Scholar 

  17. 17.

    Ecker EE, Gross P: Anticomplementary power of heparin. J Infect Dis. 1929, 44: 250-253.

    CAS  Article  Google Scholar 

  18. 18.

    Brestel EP, Mcclain EJ: A mechanism for ınhibition of luminol dependent neutrophil chemiluminescence by polyanions. J Immunol. 1983, 131: 2515-2519.

    CAS  PubMed  Google Scholar 

  19. 19.

    Ekre HP, Naparstek Y, Lider O, Hyden P, Hagermark O, Nilsson T, Vlodavsky I, Cohn I: Anti-ınflammatory effects of heparin and ıts derivatives: ınhibition of complement and lymphocyte migration. Adv Exp Med Biol. 1992, 313: 329-340.

    CAS  Article  PubMed  Google Scholar 

  20. 20.

    Nelson RM, Cecconi O, Roberts WG, Aruffo A, Linhardt RJ, Bevilacqua MP: Heparin oligosaccharides bind L- and P-selectin and ınhibit acute inflammation. Blood. 1993, 82: 3253-3258.

    CAS  PubMed  Google Scholar 

  21. 21.

    Katz DJ, Stanley JC, Zelenoek GB: Operative mortality rates for ıntact and ruptured abdominal aortic aneurysms in Michigan: an eleven-year statewide experience. J Vasc Surg. 1994, 19: 804-815.

    CAS  Article  PubMed  Google Scholar 

  22. 22.

    Lafci G, Selcuk Gedik H, Korkmaz K, Erdem H, Cicek OF, Nacar OA, Yildirim L, Kaya E, Ankarali H: Efficacy of ıloprost and montelukast combination on spinal cord ıschemia/reperfusion ınjury in a rat model. J Cardiothorac Surg. 2013, 8: 64-

    Article  PubMed  PubMed Central  Google Scholar 

  23. 23.

    Korkmaz K, Gedik HS, Budak AB, Erdem H, Lafci G, Karakilic E, Nacar OA, Yıldırım L, Ankarali H: Effect of heparin on neuroprotection against spinal cord ıschemia and reperfusion in rats. Eur Rev Med Pharmacol Sci. 2013, 17: 522-530.

    CAS  PubMed  Google Scholar 

  24. 24.

    Schneiderman J, Walden R, Bass A, Broieris S, Segal E, Adar R: Surgery for thoraco-abdominal aortic aneurysm. Harefuah. 1991, 120 (4): 179-181.

    CAS  PubMed  Google Scholar 

  25. 25.

    Gloviczki P: Surgical repair of thoracoabdominal aneurysms: patient selection, techniques and results. Cardiovasc Surg. 2002, 10 (4): 434-441.

    Article  PubMed  Google Scholar 

  26. 26.

    Gedik HS, Korkmaz K, Erdem H, Karakilic E, Lafci G, Ankarali H: Protective effect of heparin in the End organ ıschemia/reperfusion ınjury of the lungs and heart. J Cardiothorac Surg. 2012, 7: 123-

    Article  PubMed  PubMed Central  Google Scholar 

  27. 27.

    Inokawa H, Date H, Okazaki M, Okutani D, Aokage K, Nagahiro I, Aoe M, Sano Y, Shimizu N: Effects of postmortem heparinization in canine lung transplantation with Non-heart-beating donors. J Thorac Cardiovasc Surg. 2005, 129 (2): 429-434.

    Article  PubMed  Google Scholar 

  28. 28.

    Etz CD, Di Luozzo G, Bello R, Luehr M, Khan MZ, Bodian CA, Griepp RB, Plestis KA: Pulmonary complications after descending thoracic and thoracoabdominal aortic aneurysm repair: predictors, prevention, an treatment. Ann Thorac Surg. 2007, 83 (2): 870-876. Discussion 890–872

    Article  Google Scholar 

  29. 29.

    Marumoto Y, Kaibara M, Murata T: Hemorheological studies on platelet counts and size in normal pregnancy and pregnancies with preeclampsia and intrauterine growth retardation. Nihon Sanka Fujinka Gakkai Zasshi. 1989, 41 (9): 1380-1386.

    CAS  PubMed  Google Scholar 

  30. 30.

    Mauney MC, Blackbourne LH, Langenburg SE, Buchanan SA, Il K, Tribble CG: Prevention of spinal cord ınjury after repair of the thoracic or thoracoabdominal aorta. Ann Thorac Surg. 1995, 59: 245-252.

    CAS  Article  PubMed  Google Scholar 

  31. 31.

    Sahin MA, Onan B, Guler A, Oztas E, Uysal B, Arslan S, Demırkılıc U, Tatar H: Cilostazol, A type III phosphodiesterase ınhibitor, reduces ıschemia/ reperfusion-ınduced spinal cord ınjury. Heart Surg Forum. 2011, 14: E171-E1777.

    Article  PubMed  Google Scholar 

  32. 32.

    Budak B, Seren M, Turan NN, Sakaogulları Z, Ulus AT: The protective effects of resveratrol and L-name on visceral organs following aortic clamping. Ann Vasc Surg. 2009, 23: 675-685.

    CAS  Article  PubMed  Google Scholar 

  33. 33.

    Severın IC, Soares A, Hantson J, Teixeira M, Sachs D, Valognes D, Scheer A, Schwarz MK, Wells TN, Proudfoot AE, Shaw J: Glycosaminoglycan analogs as a novel anti-ınflammatory strategy. Front Immunol. 2012, 3: 293-

    PubMed  PubMed Central  Google Scholar 

  34. 34.

    Norwood MG, Bown MJ, Sutton AJ, Nicholson ML, Sayers RD: Interleukin 6 production during abdominal aortic aneurysm repair arises from the gastrointestinal tract and not the legs. Br J Surg. 2004, 91 (9): 1153-1156.

    CAS  Article  PubMed  Google Scholar 

  35. 35.

    Teoh NC, Farrell GC: Hepatic ıschemia reperfusion ınjury: pathogenic mechanisms and basis for hepatoprotection. J Gastroenterol Hepatol. 2003, 18 (8): 891-902.

    CAS  Article  PubMed  Google Scholar 

  36. 36.

    Hirsh J, Warkentin TE, Shaughnessy SG, Anand SS, Halperin JL, Raschke R, Granger C, Ohman EM, Dalen JE: Heparin and Low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety. Chest. 2001, 119 (1 Suppl): 64-94.

    Article  Google Scholar 

Download references


We would like to thank Dr. Ömer Faruk Çiçek for his help in revising the manuscript critically for important intellectual content. The authors received no financial support for the research, authorship, and/or publication of this article.

Author information



Corresponding author

Correspondence to Ali Ümit Yener.

Additional information

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

AÜY and MCÇ carried out the design and conduction of the study. SBG, BÇB and ED participated in the design of the study. HE carried out the histopathological examination. HA and TA performed the statistical analysis. TÖ revised and improved the last version of the text. All authors read and approved the final manuscript.

Rights and permissions

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Cite this article

Yener, A.Ü., Çiçek, M.C., Genç, S.B. et al. Protective role of heparin in the injury of the liver and kidney on the experimental model of ischemia/reperfusion. J Cardiothorac Surg 9, 35 (2014).

Download citation


  • Heparin
  • Ischemia
  • Reperfusion
  • Lung
  • Kidney